Trials / Completed
CompletedNCT00576849
A Total Balanced Volume Replacement Regimen in Elderly Cardiac Surgery Patients
Phase 4 Study of a Total Balanced Volume Replacement Regimen in Elderly Cardiac Surgery Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Klinikum Ludwigshafen · Academic / Other
- Sex
- All
- Age
- 80 Years
- Healthy volunteers
- Not accepted
Summary
A total balanced fluid replacement strategy is a promising concept for correcting hypovolemia. The effects of a balanced fluid management including a new balanced hydroxyethylstarch (HES) in elderly cardiac surgery patients will be studied.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Balanced HES 130/0.42 | Volume is administered perioperatively and during the first 48 hrs after surgery when mean arterial pressure (MAP) was \<60mmHg and pulmonary capillary wedge pressure (PCWP) or central venous pressure (CVP) is \<10 mmHg |
| DRUG | Balanced HES 130/0.42 | Volume will be administered perioperatively and during the first 48 hrs after surgery when mean arterial pressure (MAP) is \<60mmHg and pulmonary capillary wedge pressure (PCWP) or central venous pressure (CVP) is \<10 mmHg |
| DRUG | 6% HES 130/0.4 prepared in saline solution | Volume will be administered perioperatively and during the first 48 hrs after surgery when mean arterial pressure (MAP) is \<60mmHg and pulmonary capillary wedge pressure (PCWP) or central venous pressure (CVP) is \<10 mmHg |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2010-05-01
- Completion
- 2010-05-01
- First posted
- 2007-12-19
- Last updated
- 2010-05-27
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00576849. Inclusion in this directory is not an endorsement.